Aortic stent graft is a kind of medical device, applied in the treatment of aortic aneurysms and dissections in the areas of the thoracic and abdominal aorta. They are made up of a stent, which is a metal mesh, to reinforce the weakened aorta and combine it with a fabric graft that prevents rupture. The stent graft is inserted in a minimally invasive endovascular procedure and is delivered through the blood vessels, mostly through the femoral artery, and placed into the diseased segment of the aorta. Once deployed, it forms an effective, stable channel for blood flow, relieving the pressure against the damaged wall of the vessel.

The Aortic Stent Graft market is set to show a growth rate of about 6.8% during the forecast period (2025-2033F). Growth of the global aortic stent grafts market is broad-based and driven by a series of key factors. With a growing number of people suffering from aortic aneurysms, especially in the elderly and individuals with lifestyle-related risk factors such as hypertension and smoking, there has been a heavy demand for efficient treatments. With advancements in technology, minimally invasive procedures have become common, including endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), due to reduced recovery time and fewer complications. Moreover, the latest innovations, such as the creation of fenestrated and branched stent grafts, treatment options in complex cases further boost the aortic stent grafts market.

List of Top Companies Operating in Aortic Stent Graft Worldwide:

The global aortic stent graft market has several major players, including Terumo Corporation, Medtronic, MicroPort Scientific, Artivion, Inc., and W. L. Gore & Associates, Inc. More information about these companies has been provided below:

1.      Terumo Corporation

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

2.      Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, cardiac ablation products, and insertable cardiac monitor systems. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The company was founded in 1949 and is headquartered in Galway, Ireland.

3.      MicroPort Scientific

MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovation, manufacturing, and marketing of medical devices globally in the People’s Republic of China, Europe, the Middle East and Africa, Japan, and internationally. The company’s Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases, and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. The company’s Cardiac Rhythm Management Business offers defibrillators, cardiac resynchronization therapy devices, and pacemakers. Its Endovascular and Peripheral Vascular Devices segment provides disease solutions for the interventional treatment of thoracic and abdominal aortic aneurysms, peripheral vascular diseases, aortic dissection aneurysms, and other arteriovenous-related diseases.  

4.      Artivion, Inc.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac and preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts, including E-vita Open NEO, E-vita Open Plus, Ascyrus Medical Dissection Stent Hybrid Prosthesis, E-vita THORACIC 3G products, and NEXUS products. It also offers extra design engineering systems for the treatment of aortic vascular diseases, and an off-the-shelf stent graft for the treatment of thoraco-abdominal disease. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

5.      W. L. Gore & Associates, Inc.

W. L. Gore & Associates, Inc. manufactures electronics, fabrics, industrial, and medical products. The company offers filtration products; medical products, including implantable medical devices, thoracic stent grafts with active control systems, and medical OEM products; pharmaceutical processing products, such as pharmaceutical tubing products and molded assemblies; a 9.0 mL GORE Protein Capture Device that enables improved throughput and productivity in lead generation, optimization, and early process development in bioprocessing process development; sealants; and venting products. W. L. Gore & Associates, Inc. was founded in 1958 and is based in Newark, Delaware, with additional locations across Asia Pacific, Europe and the Middle East, and the Americas.